In a recent study, researchers sought to determine how inflammatory bowel disease affects the risk of influenza infection, and whether treatment with various IBD medications affected this risk.
There are currently no FDA-approved therapeutics for treating NAFLD, but many options are on the horizon. Steven Grinspoon, MD, discussed the options in this session.